Tspo Depletion Exacerbates Steatosis Through Fatty Acid Uptake
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yuchang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern Califor…. Hauptthemen laut MEDLINE: Fatty Acids, Receptors, GABA, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, the Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the John Stauffer Dean's Chair in Pharmaceutical Sciences (University of Southern Califor…, Liver Histology Core of the USC Research Center for Liver Diseases: NIH grant.
Abstract (Originalsprache)
Previous studies demonstrated that Tspo loss causes simple steatosis (SS) in hepatocytes in vitro. However, its effect on SS in vivo remains unclear. In this study, we hypothesise that Tspo loss promotes early‐stage MASLD. WT and Tspo KO rats were fed a Gubra Amylin NASH (GAN) diet for 8 weeks to induce SS. Tspo KO rats fed the GAN diet (KO GAN) exhibited increased insulin resistance, higher plasma cholesterol, and elevated hepatic triacylglycerol (TAG) levels, along with higher de novo lipogenesis (DNL) and free fatty acid (FFA) uptake, evidenced by increased fatty acid synthase (FASN) and CD36 expression. The Acyl‐coenzyme A binding protein/diazepam‐binding inhibitor‐TSPO complex facilitated FA transport to the mitochondria, where carnitine palmitoyltransferase 1A (CPT1A) directed them for β‐oxidation. TSPO interacted with CPT1A in the outer mitochondrial membrane, while its depletion increased CPT1A expression, boosting FA oxidation. Primary Tspo KO rat hepatocytes and stably overexpressed CD36 (CD36_OE) in Huh7 cells displayed impaired mitochondrial function and compromised mitochondrial membrane potential. KO GAN livers had significantly elevated AcCoA, which acetylated RAPTOR, activating mTORC1 to suppress autophagy. Overall, Tspo deficiency exacerbates the advancement of SS by enhancing CD36‐mediated FFA uptake, elevating AcCoA levels, compromising mitochondrial function and impairing autophagy during the early stages of MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Vassilios Papadopoulos
Förderung
- NIDDK NIH HHS
- the Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the John Stauffer Dean's Chair in Pharmaceutical Sciences (University of Southern Califor…
- Liver Histology Core of the USC Research Center for Liver Diseases: NIH grant
- University of Southern California
Zitieren
APA
Li, Y., Chen, L., Sottas, C., Patel, N. D., Raul, M. C., & Papadopoulos, V. (2025). Tspo Depletion Exacerbates Steatosis Through Fatty Acid Uptake. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70500
Vancouver
Li Y, Chen L, Sottas C, Patel ND, Raul MC, Papadopoulos V. Tspo Depletion Exacerbates Steatosis Through Fatty Acid Uptake. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70500
BibTeX
@article{Li2025,
author = {Li, Yuchang and Chen, Liting and Sottas, Chantal and Patel, Nrupa Dinesh and Raul, Mahima Chandrakant and Papadopoulos, Vassilios},
title = {Tspo Depletion Exacerbates Steatosis Through Fatty Acid Uptake},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70500}
}
EUVIMED